Peter L. Anderson

机构：University of Colorado Anschutz Medical Campus, University of Montana, University of Colorado Denver · ORCID：0000-0002-1200-8494

发表论文 372 篇 · 总被引 22267 次 · h-index 65

代表论文

• Recommendations for Interpreting Intraerythrocytic Tenofovir Diphosphate and Emtricitabine Triphosphate for HIV-1 Preexposure Prophylaxis Adherence Assessment (2025 · JAIDS Journal of Acquired Immune Deficiency Syndromes · 被引 6)
• Safety outcomes among infants whose mothers used the dapivirine vaginal ring or oral PrEP during pregnancy (MTN-042/DELIVER): a randomised phase 3b study (2025 · The Lancet HIV · 被引 3)
• A cross‐sectional study evaluating the frequency of HIV drug resistance mutations among individuals diagnosed with HIV‐1 in tenofovir disoproxil fumarate‐based pre‐exposure prophylaxis rollout programmes in Kenya, Zimbabwe, Eswatini and South Africa (2025 · Journal of the International AIDS Society · 被引 3)
• Association between substance use and PrEP adherence among adolescent girls and young women enrolled in an HIV prevention study in Southern Africa (2025 · PLOS Global Public Health · 被引 3)
• An FDA-Approved Tenofovir Alafenamide-Based Antiretroviral Therapy Reduces Biological Age in Healthy Adults: First Human Proof-of-Concept for Retrotransposon-Targeted Gerotherapeutics (2026 · medRxiv · 被引 2)
• Adherence thresholds for emtricitabine-tenofovir disoproxil fumarate preexposure prophylaxis against HIV acquisition in cisgender women: A randomized directly observed dosing study (2025 · PLoS Medicine · 被引 2)